Topline data from Phase 2 CM24 pancreatic cancer trial expected by the end of 2024 New CM24 biomarkers data presented during the third quarter of 2024 including two predicting serum biomarkers identif ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback